Indian Generic Price

The study highlights the need to modify the drug price policy, regulate the mark-ups in generic supply chain, conduct and widely publicize the quality testing of generics for awareness of all stakeholders. Supply chain management practices backed by IT-based platforms have shaped estimation, tracking, and monitoring practices for medicines, equipment, and consumables in the Indian health system. Early implementation of such platforms is identified as a key determinant to promote skill development and skill refinement among trained users, allowing the states to gradually saturate and establish them throughout.

“We spend a lot of time at work; we should enjoy it.”

However, it must be noted that Novartis provides Glivec free of charge to 16,000 patients in India, roughly 95% of those who need it via the Novartis “Glivec International Patient Assistance Program”. The remaining 5% are either reimbursed, insured, or participate in a very generous co-pay program. Thus, not granting a patent for Glivec really hasn’t prevented patients from getting this life-saving medication. Dr. Reddy’s Laboratories, a well-known global pharmaceutical company, manufactures Cabzored as part of its oncology treatments. (launching link) It is designed to offer a cost-effective and accessible treatment option for patients with specific types of cancer. In fact, the physicians have also cited other reasons for not prescribing generic medicines.

• According to a 2022 study released by GS1 India, a global supply chain standards organization, more than 50 per cent of Pharma and medical devices manufacturers lose 1 per cent of their sales due to expiry and pilferage.
• Although we reported availability, stock-outs and affordability of medicines in the PMBJP pharmacy outlets, a more comprehensive assessment of the accessibility of essential medicines may have included measurement of medicine prices, prescription pattern and out-of-pocket payments on medicines.
• The pharmacists, they claimed, will sell noneffective, or highly overpriced drugs once the authority to decide the drug for a given indication is bestowed upon the pharmacists through the policy of compulsory active ingredient prescribing.
• In India, many pharmaceutical companies manufacture two types of products for the same molecule, i.e. the branded product which they advertise and push through doctors and branded-generic which they expect retailers to push in the market.
• Under the DPCO, manufacturers are required to be aware of price fixation and revision by the NPPA since it is mandatory to follow the ceiling prices fixed and notified by the NPPA.

Pharmacists’ views on PMBJP

Drugs registered under DPCO must be sold within the price range, which is mandatory for the company and therefore, the break-even point is sometimes barely reached (Paul, 2018). Indian companies will continue to expand globally, enriching their manufacturing capabilities to meet the growing demand in the world. The future will see a major role in global healthcare by enzalutamide price in thailand Indian pharma, not only in making medicines affordable, but also in strengthening India’s position as a global hub for making innovative and high-quality medicines. These policy issues, along with market forces, drive the response of the public and private sectors to reimbursement policies, as well as determine the extent of price control on pharmaceutical products.

Beginning of Generics

Further, the private physicians underlined the need for developing strong regulatory mechanisms to ensure that generic drugs meet high standards of quality. “We are ready to prescribe low cost generics, but it becomes difficult for me to convince my patients to take such a low-cost generic medicine. Most of the time patients want relief from pain as quick as possible and thus they are ready to pay even high for medicines. We first examined the selected medicine list of PMBJP to assess the extent of coverage of essential medicines. NLEM, 2015 has 376 essential drugs whereas the PMBJP list contains 214 essential medicines.

Media Services

It is administered orally and requires careful dosing and monitoring by healthcare professionals to manage side effects and ensure the best therapeutic outcomes. Ms. Chawla has authorised and contributed to various academic articles and journals on topics relating to cyber laws and copyright laws. She has represented the firm at national and international conferences and conclaves in India and Dubai. Further, she has also conducted workshops on IP law for university students and has been invited as a judge for several prestigious moot court and negotiation competitions at the university level.

Do all drugs have generic versions?

Maria Rosaria Carli was formerly Director of the Institute of Research on Mediterranean Economies of Italian CNR. Her research interests are focused on Economics of Development and she was Adjunct Professor of Economics of Developing Countries at the “Parthenope” University of Naples, Italy. She was Italian member of the Core Group and Standing Committee for the Social Sciences – European Science Foundation. She is scientific coordinator for the CNR on R&D projects and has published articles on national and international journals, as well as essays on collective volumes. After all, a clear understanding of our record of accomplishment and emphasis on quality supports the ongoing efforts of Indian generic manufacturers to provide quality solutions that ultimately benefit consumers across the globe. This medication is administered under the guidance of an oncologist and has specific dosing instructions to ensure effectiveness and minimize side effects.

Buy generic Cazanat (Cabozantinib) in India

In the above, API stands for Active Pharmaceutical Ingredient and AYUSH stands for Ayurveda, Yoga, Unani, Siddha and Homeopathy. Starting in 2014 in India, a Ministry of AYUSH was established, indicating the extraordinary relevance in the country of these specific items. More focus on patents for innovative drugs is required, instead of concentrating primarily on generic drugs. There is a need for policymakers to work on the sustainability and development of the industry, while the companies must redesign their orientation toward enhancing innovation capabilities. In addition, at the level of corporate strategy, firms should establish collaborations and alliances and expand their industrial marketing vision.

• Additionally, barriers in communication and coordination between the states, districts, healthcare facilities, and procurement bodies cause duplication of purchases.
• Given this as background, we are presenting a study, in that linear discrimination analysis (LDA) models for deducing the correlations between acceptable quality attributes of AMLO FPPs and independent variables would be helpful in establishing outcome effects.
• In many cases the generic drugs do not produce the desired effect in the expected time which branded ones do.
• The cost of generic medicines of PMBJP outlets for treating various conditions range from 0.01 days’ wages to 0.47 days’ wages for the lowest paid unskilled worker in Maharashtra.
• The medicine will be only for personal use and not more than 3 month supply at a time.
• An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
• Price-to-patient (MRP) and price-to-retailer (PTR) found for all the five ‘pair’ of medicines is tabulated in Table 1.
• These calculations, as emerging from Figures 2 and 3, allow us to respond positively to RQ2 (“Are the expectations about the trade balance positive or negative?”).
• Particularly, the country exports generic medicines on a large scale, with a major impact in the American and European markets.

A narrative strengths, weaknesses, opportunities and threats analysis of the Indian pharmaceutical industry

Table 3 shows the extent of availability of medicine at PMBJP pharmacies across all levels of care in Mumbai and Palghar. Overall, the mean availability of medicines across study districts was found to be 52%, though the mean availability of medicine was slightly higher in Palghar (54%) than in Mumbai (51%). The findings suggest that availability of medicines vary significantly, ranging from 8 to 72% in Palghar and from 0 to 83% in Mumbai.

Unlock your potential to drive healthcare forward

According to National Sample Survey Organisation, public facilities accounted for only 30% of the overall healthcare services in the year 2017–18 [4]. This means that majority of the people had to obtain healthcare including medicines from private providers. Moreover, even those who access healthcare from public facilities end up purchasing drugs from the market as the prescribed medicines are often not available in pharmacies of public hospitals. Currently, almost all medicines in India are sold under a brand (trade) name and medicines are called as branded medicines or branded-generic. In real sense, Indian market does not have branded medicines (a name commonly given to an innovator product) because till January 2005 product patent was not applicable in India.

Worth the price? Push for cheaper generic drugs has Canadians buying questionable medicines from India

The company ignored tests showing unknown impurities in some drugs, and inspectors came across samples with bacteria and mould that were “TNTC,” too numerous to count. What that patient is unlikely to know is the drug’s active ingredients come from a company called Dr. Reddy’s Laboratories Ltd. in India — or that U.S. inspectors made some eye-opening discoveries recently at the plant that produces them. The medicine will be only for personal use and not more than 3 month supply at a time. Quality and price of medicines were studied to evaluate the two versions of the same therapeutic molecule.

Authors would like to thank the pharmacists, PMBJP pharmacy owners and physicians who participated in the study. The survey was conducted in two districts of Maharashtra, namely Mumbai metropolitan region and Palghar. In terms of per capita income, Maharashtra is one of the richer states in India and Mumbai is its capital city. With a population of more than 20 million, the city is one of the most populous urban centres in the world. It has the distinction of being home to the largest slum population in any city in the world, displaying a high level of income inequality.

See markets more clearly. Opportunities more often.

And while the Republicans generally favor more market-based solutions—including the importation of drugs from other countries and increased price transparency—reducing drug costs in the U.S. has become one of the few bi-partisan issues. To compare and evaluate the price and quality of “branded” and branded-generic equivalents of some commonly used medicines manufactured by the same pharmaceutical company in India. Prior to that, the state level commitment for free medicine policy had been differential. Fund shortages pushed states to appropriate budget heads under benefit schemes (e.g., Janani Shishu Suraksha Karyakaram- JSSK) or use revenue from services like diagnostics to ensure the provision of free medicines, thereby shifting the burden to other determinants of OOPE.

• Faced with shortages and a limited number of suppliers, almost all of them overseas, the FDA is actually being forced to relax its standards, just to find any supplier of certain badly-needed drugs.
• Generic Aadhaar is giving identity to the old medical stores and making it easy for them who are dealing with huge competition and online Pharmacy in the Market.
• There is also a presence of good technical and technological expertise together with the availability of low-cost skilled human resources.
• In terms of per capita income, Maharashtra is one of the richer states in India and Mumbai is its capital city.
• In spite of being the ‘pharmacy of the world’, access to essential medicines for a large majority of Indians is constrained by both physical and financial reasons.
• Capacity building of skilled cadres across the levels of care like facility-in-charge, store-keepers, ANMs and pharmacists in inventory/ material management, demand estimation, and indenting is required to support their state-specific practices.
• Currently, almost all medicines in India are sold under a brand (trade) name and medicines are called as branded medicines or branded-generic.

Any medicine information provided on this website is for informational purposes only and is not a substitute for specific or medical advice. That’s why the launch of this drug will make it more affordable for breast cancer patients to manage the disease. For treatment of breast cancer, Palbociclib is administered with hormone (endocrine) therapy. By our calculations, China’s global share of formulations exports trebled from 0.4% in 2009 to 1.2% in 2018, while India’s doubled over the same period from 1.5% to 3.6%.

This will be a tough balance to achieve, but it appears that all stakeholders recognize the urgent need for it to occur. Nearly 1 in 10 Americans said they believe generic drugs aren’t tested as rigorously as brand-name, with Gen Z being the most likely to have this view (11%). Some also questioned whether generics are FDA-approved (7% of Gen Z), and 12% of Millennials believed that generics took longer to work compared to brand-name medications.

Industry Products

Regulatory authorities need to provide more emphasis on quality control of generic medicines.” (P4). “We are ready to prescribe generic only, but there is no mechanism to ensure that private pharmacy shop chemists would dispense right and cost-effective generic medicines. Because there are hundreds of generics with different prices are available in the market, chemists can substitute for prescribed medicine as per their wish and earn high profit margins. Clinicians working in the public sector said that they prescribe 99% medicines in generic form as the government supplies only generic medicines to public health facilities.

This is the first limitation of the research, thus, further investigations expanding the range of the data under examination would improve the reliability of the results. In value terms, the sector, considering the total manufacturing of pharmaceuticals, medicinal chemicals and botanicals (Table 1), is worth Rs. 145,841.1m in 2018–2019. The largest market share concerns ayurvedic and homeopathic medicaments (AYUSH medicines) with 24.37%, followed by antibiotics (API and formulations) with 18.82%, and anti-retroviral drugs for HIV (Human Immunodeficiency Virus) treatment with 15.89%. These three pharmaceutical categories alone are worth approximately 60% of the entire Indian pharmaceutical production.

However, as shown in Table 2, PMBJP medicine list has as many as 130 FDCs in different therapeutic categories. The maximum number of fixed dose formulations listed in PMBJP is for vitamins and micronutrient deficiency followed by gastrointestinal complaints and cardiovascular disorders. As a protectionist tide sweeps across the globe, the Indian pharmaceutical industry needs to continue evolving.

If these Jan Aushadhi stores are available in Government hospital premises, patient can get those medicines easily.”(PuP2). If government wants us to prescribe drug through their molecule names, why do they allow so many brand names and why are there such wide price variations? By doing so, the brand has presented a cost-effective treatment for many patients of (HR+) (HER2-) advanced or metastatic breast cancer patients. Learn more about the Indian generic versions of Palbociclib and how it is a breakthrough in breast cancer treatment.

There are only 74 bulk drugs which are under price control[15]and are called scheduled medicines. For scheduled medicines, the NPPA pricing formula sets the 8% mark-up for wholesalers and 16% for retailers. For non-scheduled medicines, these markups are not set, but it is agreed by the partners of the trade that for branded medicines average mark-up would be around 10% and 20% for wholesalers and retailers, respectively. Diverse systemic determinants of access to quality and affordable medicines have been documented through CRMs. Though not an exhaustive list, state-specific experiences over the years highlight the determinants of access, and pertinent systemic challenges needing redressal.

This chapter has been written by a member of GLI’s international panel of experts, who has been exclusively appointed for this task as a leading professional in their field by Global Legal Group, GLI’s publisher. GLI’s in-house editorial team carefully reviews and edits each chapter, updated annually, and audits each one for originality, relevance and style, including anti-plagiarism and AI-detection tools. All methods were performed in accordance with the relevant guidelines and regulations. The study protocol was approved by the School of Health Systems Studies, Tata Institute of Social Sciences, Mumbai. Besides, the permission to conduct the study was obtained from Bureau of Public Pharmaceutical Undertakings (BPPI), Department of Pharmaceuticals, Government of India. The informed written consent of study participants’ including the pharmacists of surveyed PMBJP outlets was obtained prior to conducting interviews and reviewing stock records.

We found that switching from branded-generic medicine to unbranded generic medicines would lead to substantial cost savings for medicine consumers. Our estimates suggest that unbranded generic substitution would reduce pharmaceutical expenditure by 6–1129% of patient’s spending. However, caution must be exercised while interpreting affordability because of the following reasons. First, affordability might differ depending upon the compliance of the minimum wages act of the Maharashtra government. Second, the level of economic development varies considerably across states and between rural and urban areas in India and this needs to be taken into account while extrapolating results of this study to other states and national level.

One of the reasons for this decrease was the transition of the pricing strategy from cost-based to market-based policies, a noticeable cause due to the implications deriving from DPCO (PTI, 2013). The legal framework for intellectual property rights, i.e. the law and policy relating to patent protection and/or compulsory licensing, also affects the availability and pricing of pharmaceuticals, especially innovative and biologic drugs. Further, international pricing trends and regulations, as well as global supply chain disruptions, have immense influence on local drug pricing and availability in India, particularly for those drugs for which there is no local production and reliance is purely on exports.

The mean drug availability at PMBJP stores located in the vicinity of PHCs and district/rural hospitals was 51% and 61% respectively. While more than 70% of PMBJP pharmacies across all levels of care in Palghar region had palliative care medicines, anti-epileptics, analgesics and antacids, the availability of anti-cancer, anti-asthmatic and electrolyte balancing drugs were found to be very poor (less than 30%). Aside from collecting primary data, secondary data such as the price information of some PMBJP medicines and their leading brand name counterparts (in terms of market share) were gathered from the web portals of PMBJP and MedGuideIndia.com respectively. The website provides information on a wide range of drugs available in the Indian pharmaceutical market including their prices.

Regulations to support mandatory generic prescribing and generic substitution by pharmacists are needed. The cardiovascular disease (CVD) treatment market is one of the leading pharmaceutical markets in India, as the country accounts for one-fifth of all cardiovascular-related deaths worldwide. According to national statistics, India’s cardiovascular market was worth $2.52bn in 2022 and is forecast to reach $4.26bn by 2030. Consequentially, there is a strong emphasis on generic CVD drugs over branded drugs due to their affordability.

Hence, consumer awareness for the generics, variety of trade names available in the market, and price variation is very limited. Hence, there is need to conduct a study that can document the price structure and quality of the branded product and their branded-generic versions manufactured in India. Difference in price-to-patient was not as huge as it is expected for generics but margins for retailer were very high for branded-generics.

There are a large number of drugs that went off patents, providing many pharmaceutical companies with huge opportunities to enter the market. The increased inclination toward the health insurance sector and the growth of per capita income have expanded the purchasing capacity of patients/consumers, providing a long-term perspective for the development of the pharmaceutical sector. Hence, India can become a global outsourcing hub for pharmaceutical products due to its low-cost production ability combined with FDA-approved manufacturing plants (Vaidya et al., 2018). While drug pricing control on essential medicines is critical to ensure affordability and access to pharmaceutical products, it may have an adverse effect on value creation and innovation in pharmaceutical products. Therefore, another key policy aspect which ought to operate in tandem with drug pricing is drug reimbursement, i.e. rules and processes that determine the amount and conditions under which healthcare payers will pay for pharmaceutical products.

Both countries have used government subsidies, export incentives, and other tools to lower their costs of production and build locally-owned drug manufacturing centers. One of the foremost challenges confronting the Indian pharma supply chain is regulatory compliance. The industry operates within a complex regulatory landscape characterized by stringent quality standards and evolving regulations. Ensuring compliance with diverse regulatory requirements across different markets poses a considerable challenge for Indian pharmaceutical companies as it would for any company operating globally and subject to multiple jurisdictions. The pharmaceutical business function of R&D has been significantly affected by the DPCO. Due to price controls, companies have not dedicated themselves to inventing and developing new medicines.

(2016), “R&D, technology transfer and productivity in the Indian pharmaceutical industry”, International Journal of Innovation Management, Vol. The infrastructure of the industry and the R&D capabilities of domestic businesses have improved considerably in recent years, but many challenges remain, mainly related to pricing regulation, sector fragmentation and intellectual property. Not surprisingly, all of them, directly or indirectly, concern patents, which are central issues of debate in the national industry. Tiered pricing, also known as differential pricing , is often practised by pharmaceutical companies based on the ability of countries to pay, but Hill was unavailable to comment. Several factors have contributed to this significant growth of the healthcare industry in India – which includes a combination of public sector initiatives and expansion of private-sector enterprises.

Please keep the item in its original condition, original packaging, with user manual, warranty cards, and original accessories in manufacturer packaging for a successful return pick-up. For software-related technical issues or installation issues in items belonging to the Software category, please contact the brand directly. Wind instruments and items marked as non-returnable on detail page are not eligible for return.

Generic Medicine Products

In addition, the thrust on rural health programmes, lifesaving drugs and preventive vaccines also augurs well for the pharmaceutical companies. The active component will be listed on the drug label if your doctor allows generic replacement, even though your prescription is for a brand-name product. As a result, the active components in brand-name and generic medications are identical. Trade regulations prohibit identically branded generic medicines, but they must all contain the same active ingredients to produce the same therapeutic benefits.

Trending news

The company develops pharmaceuticals in different formulations, including liquids, ointments, tablets, capsules, injectables, granules and powder. These products cater to the treatment of gastroenterological, gynaecological, urological and neurological diseases, as well as diabetes, pain and infections. Headquartered in Gurgaon, Fortis Healthcare Limited is an IHH Healthcare Berhad subsidiary and is a prominent integrated healthcare services provider in India. With 28 healthcare facilities and over 400 diagnostics centres across India, the United Arab Emirates (UAE), Sri Lanka and Nepal, it is among the country’s largest healthcare organisations.

These pharma start-ups are making medicines affordable, cutting monthly budget by half; here’s how

These medicines have the same potency, quality, and implications and work in an identical manner as the branded drug. The conditions under which medications are produced differ between brand-name and generic drugs. While a generic drug is made using the same active ingredient as a brand name drug, a brand name drug refers to the name provided by the producing business. Although sunitinib price in malaysia they are sold with numerous names, generic drugs will share the same active ingredients as their branded counterparts. Except for composition patents for foods and medicines, the Patents Act covered the process patent, which was shortened to five to seven years. The Medical Council of India’s 2002 code of ethics advises doctors only to prescribe drugs by their generic names.

Ajanta Pharma

There is no infringement, ruled a US appeals court which rejected Genentech’s bid to block Sandoz’s copycat version of Esbriet, dealing a hard blow to the innovator company. We will be happy to have you on board as a blogger, if you have the knack for writing. M&A transactions have increased by 13.5% year-on-year, reaching a total value of US$ 88.9 billion, while the number of deals has risen by 25.9% to 2,811 in the first eleven months of 2024. Exports of Drugs & Pharmaceuticals were estimated to be at US$ 2.13 billion in January 2024, accounting for 5.8% of the total exports in the month. India is the 3rd largest producer of API accounting for an 8% share of the Global API Industry.

India’s largest private

50% of people prefer to purchase generic over branded medicines while 47.8% believe branded drugs are more effective than generic. On April 2017, the Medical Council of India released a notification which stated it is mandatory for the physicians to prescribe the drugs by using generic names. The infusion of generic substitution is supported by health authorities in several developed countries and why it is important to conduct bioequivalence tests and prescribing drug spending. Such requirements might raise the generic drugs prices a bit but is useful in lowering the overall healthcare expenses. Somehow these practices will also combat with the distrust for the generic medicines amongst people who perceive such drugs as of inferior quality and counterfeit of the branded drug. The foremost thingabout generic pharmaceuticals is that they are developed with same chemicalcompositions as the brand medicines.

• Some of the patents claimed to have been infringed were invalid, the appeals court said.
• “ The penalty would clearly be a multiple of the profits that these companies pocketed from the extraordinary price hikes,” said Vishal Manchanda, an analyst at Nirmal Bang Securities Ltd.
• Zeelab Pharmacy specializes in providing you with affordable medicines online at the comfort of your home.
• Because producing them is either too difficult or too expensive for their original creators.
• The tariff hike presents an opportunity for Indian pharmaceutical companies to expand their presence in the US, provided they meet the stringent demands for quality, efficiency, and agility.
• The conditions under which medications are produced differ between brand-name and generic drugs.

Does every branded drug have a generic counterpart?

• “Investing in capacity building, transparency, and flexible supply chains will be crucial,” Datta said.
• With the response received for being a COCO store retail partner we look forward to deep penetration across the Indian terrain.
• Our company is dealing in wholesale generic medicines distribution as well as branded medicines which are still under the patent act and are not available in generic medicines.
• Jason Kolbert, an analyst with Maxim Group, sees Teva, with its vast geographic reach and huge product portfolio, as a “direct beneficiary” of Indian drug company setbacks.
• We have total 2000+ products available, which includes “Generic medicine, Health & Wellness, OTC, Cosmetics, Protein Supplements, Gym Supplements, Nutracutical, Ayurvedic & Surgical prodcuts”.

For the past five years, he has been at the forefront of realizing Zota’s core objective—sourcing the highest quality products at the most competitive prices. His expertise in sales has played a pivotal role in developing mechanisms to optimize inventory levels while ensuring cost vigilance. Transitioning to a pivotal role within Zota Healthcare, he undertook the critical task of sourcing products from reputable manufacturers. Managing thousands of SKUs across multiple divisions demanded extraordinary skills in streamlining procurement processes while maintaining a keen focus on cost-effectiveness. After FDA approves any medicine, including generics, it continues to examine the medicine’s safety.

Indian companies eye new trade channels in US amid erosion of generic prices

Also, the pharmaceutical industry has shown tremendous progress and adapted to a changing environment which will help in achieving more success in generic drugs export from India. Furthermore, the Covid-19 pandemic has boosted the exports of generic medicines to a great extent, the developed and developing world are concerned about the high costs of patented medicines and looking for cheaper alternatives. Many countries across the globe are keen to use more generic drugs in the long run to cut down the cost of healthcare. This scheme is currently running in each state of India with its high popularity among the people with average to low-income categories providing the public access to affordable branded medicines.

Survanta Injection Generic Drugs

Moreover, the proposed US Biosecure Act is an important factor for the Indian pharmaceutical industry. The Act aims to reduce US biopharmaceutical companies’ reliance on Chinese manufacturing by January 1, 2032, providing a seven-year timeline for implementation. Dr. Mansukh Mandaviya, Union Minister for Chemicals & Fertilizers and Health & Family Welfare virtually inaugurated 27 greenfield bulk drug park projects and 13 greenfield manufacturing plants for medical devices, here today. Jan Aushadhi Sugam application helps citizens search for nearby Jan Aushadhi Kendra. Citizens can search for generic medicines and provide feedback and suggestions, as well as report bugs encountered while using the application.

The demand of Generic Medicine in Indian Drugs Market

Yes, The generic medicines have similar efficacy and therapeutic value as that of the branded medicines. Government Patent Law do not allow a generic medicine or medicine to look exactly like other medicines already on the market. Generic medicines and brand-name medicines share the same active ingredient, but other characteristics, such as colors and flavourings, that do not affect the performance, safety, or effectiveness of the generic medicine, may be different. Illegitimate drugs have been a challenging issue for India over quite a period of time.

• But, customers need to pay more attention to the availability of different generic drugs that are also cost-effective.
• Ans 2.) No, it is not both medicines have the same active pharmaceutical ingredients.
• Employees based out of 50+ offices all over the world working towards one mission – Enriching lives globally.
• For this reason, before enabling generic drug manufacturers to create and market the same medication, the legislation first allows the brand-name firm to recoup its investment.
• The objective of the scheme is to transform Indian pharmaceuticals sector from cost-based to innovation-based growth by strengthening the research infrastructure in the country.

Akums zeal and capability to create a significant increase in productivity are valued by Lupin.

To know the generic name of the medicine you are looking for, you can also use a free web service such as This website has a database of over 1 lakh medicines. Before investing, investors must conduct independent research and not solely rely on the information provided here. This will allow investors to make appropriate investment decisions based on their financial goals, investment objectives and risk tolerance.

In other words, their pharmacological effects are the same as those of their brand-name counterparts. Giving you an example of a generic drug is generic drug for diabetes is metformin. As per estimates, about 60% of Indians cannot afford to buy their daily medicines. The drug prices include marketing and promotional costs which cut down on the public’s wallet.

Though other markets may face a more moderate tariff increase of 10% to 20%, the focus on Chinese goods aims to strengthen US manufacturers. The pharmaceutical generics sector, heavily reliant on Chinese supply chains, is expected to be most affected. The PLI scheme for bulk drugs will lead to reduced import dependence and better supply chain resilience.

Hospira is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness™ by developing, manufacturing, and marketing products that improve the productivity, safety, and efficacy of patient care. In February 2007, Hospira acquired MaynePharma Limited to become the world leader in specialty generic injectable pharmaceuticals. Dawaa Dost tied up with noted pharma companies to ensure that the best quality medicines are provided at the right price. In addition to its online presence spanning 19,000 pin codes across India, Dawaa Dost has 69 retail stores in 10 cities. Davaindia Generic Pharmacy a chain for generic pharmacy retail outlets across India established in 2017 with the aim to provide affordable and quality medicine to all and doing that have provided Happiness of Good Health for all.

Popular Stocks

We have analyzed and compared the historical data, activities, revenue forecasts, and growth rates of our listed generic companies. The company is also involved in the developmental capabilities covering fusion proteins, monoclonal antibodies, antibody-drug conjugates, and vaccines. It has a robust pipeline comprising of next-generation biosimilars and novel biologicals. Cipla India business chief executive officer and executive vice president Nikhil Chopra said in an emailed statement that the company was launching Cipremi commercially on Wednesday and aims to supply over 80,000 vials within the first month. The expanded list of companies includes Dr. Reddy’s Laboratories Inc., Emcure Pharmaceuticals Ltd, Glenmark Pharmaceuticals Inc., Sun Pharmaceutical Industries Inc., and Zydus Pharmaceuticals (USA) Inc. For seller-fulfilled items from Sports collectibles and Entertainment collectibles categories, the sellers need to be informed of the damage / defect within 10 days of delivery.

The beginning is with one disease and one leads to another, medicines and dosages increase and so does the cost. Following this, the Union Ministry of Health informed that though a generic prescription is a must, brand names can be mentioned in parentheses. But, this again deviated from prescribing generic names with an intent to exclude branded names from prescriptions. A few years ago, while inaugurating a private hospital in Rajasthan, Prime Minister Narendra Modi announced that prescribing medicines in generic names shall be mandatory for all medical practitioners. As Director, he continues to lead Zota Healthcare with a commitment to innovation and excellence, driving the company toward sustained success.

Join the community of 2M+ industry professionals

• It is acceptable for a doctor to prescribe or supply medications, remedies, and appliances, as long as patients are not exploited.
• As per the survey conducted in 2014 by the National Sample Survey Office (NSSO) on healthcare shows the staggering number of 82% in urban and 86% of the rural population not covered under any scheme of health expenditure support.
• Additionally, currency fluctuations pose a risk, given the industry’s reliance on exports.
• The country leads in generic drug manufacturing, accounting for 20% of the global supply by volume and meeting about 60% of the world’s vaccine demand.
• At Zeelab Pharmacy we offer you with an option to receive genuine and relevant consultation from our team of best doctors and healthcare professionals.
• From respiratory to neurology and analgesics, explore the diverse therapeutic applications for both local and systemic relief.

When a doctor prescribes or acquires medications for a patient, the medicine’s original formula and generic name must be clearly stated. Non-compliance with these regulations amounts to ‘professional or ethical misconduct’. Before the patent on the brand-name medication expires, the authority can give “tentative approval” to a generic version. Numerous businesses may produce and market generic versions of the same product under different brand names. However, it’s feasible that some drugs will never have a generic alternative. Because producing them is either too difficult or too expensive for their original creators.

India supplied around 45 tonnes and 400 million tablets of hydroxychloroquine to around 114 countries globally. The Indian pharmaceutical industry has seen a massive expansion over the last few years and is expected to reach about 13% of the size of the global pharma market while enhancing its quality, affordability, and innovation. You are not alone if you worry that generic medications are less expensive and could have lower quality. The regulator strives to make generic medications as secure and efficient as brand-name medications.

• As per the FICCI Report on Indian pharma industry (2021), India’s pharma industry has demonstrated a compounded growth rate of (CAGR) of about 11% in the domestic market, while the exports have registered a 16% growth over the last two decades.
• 50% of people prefer to purchase generic over branded medicines while 47.8% believe branded drugs are more effective than generic.
• Otherwise, we may face the paradox of being pushed out of our own home market while attempting to enter higher-value export markets,” he said.
• For seller-fulfilled items from Fine Art category, the sellers need to be informed of the damage / defect within 10 days of delivery.
• Out of 92, 70% of them understand the difference between branded and generic drugs while 14% of 92 believed that generic drugs were not cheaper than branded drugs.
• The demand for pharmaceuticals is influenced by various factors such as ageing populations, increasing healthcare spending and disease prevalence.
• Wherein 74% is allowed under the automatic route and thereafter through the government approval route.
• In this regard the sector has seen a lot of investments and developments in the recent past.

His efforts not only involved appointing and nurturing new business partners but also elevating sales to unprecedented levels, setting new benchmarks for success. His dynamic leadership led the Zota Health Care Limited to become a major player in Pharma Industry. He is entrusted with the responsibilities of looking after the planning and implementing new marketing strategies and projects of the Company.

The Pharma sector currently contributes to around 1.72% of the country’s GDP. Because of the high pricing of branded medicines generic drugs are introduced. A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, kinetics, way of administration, quality, and intended use. The development of new drugs is protected by patents, which typically last for 20 years after approval. However, developing and marketing the branded medication might take a long time.

The generic manufacturer often gives huge trade discounts but fails to reach the buyer. A chemist will always push medicines that offer more margin even if the generic medicine of that company remains higher than other generic medicines. According to study, the Indian generic drugs market stood at USD 24.53 billion in 2022 and is expected to grow at a steady compound annual growth rate (CAGR) of 6.97% during the forecast period.

The expanding healthcare infrastructure, combined with increasing demand for healthcare services and products, presents growth opportunities for pharmaceutical companies. Abbott India Limited is a subsidiary of Abbott Laboratories with its headquarters in Mumbai. The company specialises in discovering, developing, manufacturing and marketing various branded generic pharmaceuticals, nutritional products, diagnostic tools, and vascular and diabetes devices. India is also the largest provider of generic medicines globally, occupying a 20% share in global supply by volume.

His substantial contribution has helped India become a major player in healthcare across the globe. In India, Abbott develops and distributes more than 600 healthcare products to promote the health and well-being of citizens at all stages of life. Pfizer’s product portfolio includes vaccines, cardiac medications, maternal nutrition supplements, anti-infectives, gastrointestinal drugs, pain relievers, anti-inflammatory drugs, contraceptives, nutrition and immunity boosters and respiratory medications.